Panel To Decide Future Of DOE Records

G. CHRISTOPHER ANDERSON WASHINGTON—The Department of Energy, reacting to congressional pressure and criticism of its epidemiology program, has asked a new advisory panel for help. The move is aimed at defusing an increasingly volatile dispute between environment and health activists and the energy department over the health records of 600,000 DOE nuclear weapons plant workers (The Scientist, Aug. 7, 1989, page 1). Meeting last month for the first time with his Secretarial Panel for t

Written byChristopher Anderson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

G. CHRISTOPHER ANDERSON

WASHINGTON—The Department of Energy, reacting to congressional pressure and criticism of its epidemiology program, has asked a new advisory panel for help. The move is aimed at defusing an increasingly volatile dispute between environment and health activists and the energy department over the health records of 600,000 DOE nuclear weapons plant workers (The Scientist, Aug. 7, 1989, page 1).

Meeting last month for the first time with his Secretarial Panel for the Evaluation of Epidemiological Research Activities, Energy Secretary James Watkins said he wanted advice on all management aspects of the epidemiology program, including “the utility and feasibility of transferring the epidemiologic research function, including the necessary data, to another agency. Congress is weighing two proposals to give another federal agency the responsibility for the research.

So far, the agency has allowed only DOE researchers to analyze health data that it has maintained on nuclear weapons workers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies